Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

485

datasets available to search

ShareScore release 0.7.1

Reset

Dataset results

485 results for “Photodynamic therapy”

Learn how ShareScore rates datasets ↗
zenodo36/100

Data for 'Simulating Photodynamic Therapy for the Treatment of Glioblastoma using Monte Carlo Radiative Transport'

<p>Files added include the data used to make each data plot within the paper.</p> <p>Figure 5:</p> <p>pen_depth_plot.py</p> <p>pen_depth_plot_y.py</p> <p>pen_depth_plot_z.py</p> <p>jmean_run2NB.dat</p> <p>o21_full_run2NB.dat</p> <p>rhokap_run2NB.dat</p> <p>tumour.dat</p> <p>&nbsp;</p> <p>Figure 6:</p> <p>tumour_percentage.py</p> <p>tumkill_full_994.dat</p> <p>tumkill_full_1.dat</p> <p>&nbsp;</p> <p>Figure 7:</p> <p>temp_run2NB.dat</p> <p>max_temp_timeNB.dat</p> <p>&nbsp;</p> <p>Figure 8:</p> <p>power_run2NB.dat</p> <p>s0_slice_run2NB.dat</p> <p>o23_slice_run2NB.dat</p> <p>o21_slice_run2NB.dat</p> <p>temp_slice_run2NB.dat</p> <p>&nbsp;</p> <p>Figure 9:</p> <p>percent_left_run2NB.dat</p> <p>percent_left_run11NB.dat</p> <p>percent_left_run12NB.dat</p> <p>percent_left_run13NB.dat</p> <p>&nbsp;</p> <p>Figure 10:</p> <p>percent_left_run1NB.dat</p> <p>percent_left_run2NB.dat</p> <p>percent_left_run3NB.dat</p> <p>percent_left_run4NB.dat</p> <p>&nbsp;</p> <p>Figure 11:</p> <p>max_temp_time_run1NB.dat</p> <p>max_temp_timeNB.dat</p> <p>percent_left_run1NB.dat</p> <p>percent_left_run2NB.dat</p> <p>&nbsp;</p> <p>Figure 12:</p> <p>percent_left_run2NB.dat</p> <p>percent_left_run10NB.dat</p> <p>max_temp_time_run10NB.dat</p> <p>max_temp_timeNB.dat</p> <p>&nbsp;</p> <p>Figure 13:</p> <p>percent_left_run2NB.dat</p> <p>max_temp_timeNB.dat</p> <p>percent_left_run9NB.dat</p> <p>max_temp_time_run9NB.dat</p> <p>&nbsp;</p> <p>Figure 14:</p> <p>percent_left_run2NB.dat</p> <p>percent_left_run14NB.dat</p> <p>percent_left_run15NB.dat</p> <p>&nbsp;</p> <p>Figure 15:</p> <p>percent_left_run2NB.dat</p> <p>percent_left_run56NB.dat</p> <p>percent_left_run62NB.dat</p> <p>max_temp_time_run56NB.dat</p> <p>max_temp_timeNB.dat</p> <p>&nbsp;</p>

opencc-by-4.0Aug 2023View details →
ClinicalTrials.gov36/100

Dose-finding Study of Hexaminolevulinate (HAL) Photodynamic Therapy (PDT) to Treat Cervical Neoplasia

ClinicalTrials.gov study NCT01256424. IPD Sharing: Not stated. Countries: 2. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Ranibizumab Versus Low-fluence Photodynamic Therapy in the Treatment of Chronic Central Serous Chorioretinopathy

ClinicalTrials.gov study NCT01325181. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses

ClinicalTrials.gov study NCT06027619. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

The Use of Microneedles to Expedite Treatment Time in Photodynamic Therapy

ClinicalTrials.gov study NCT02594644. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Photodynamic Therapy Using Porfimer Sodium in Treating Patients With Recurrent Mouth or Throat Dysplasia or Recurrent In Situ Cancer or Stage I Cancer of the Mouth or Throat

ClinicalTrials.gov study NCT00530088. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Photodynamic Therapy With Porfimer Sodium in Treating Patients With Precancerous Lesions, Cancer, or Other Disease of the Aerodigestive Tract

ClinicalTrials.gov study NCT00453336. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Ultrasound-Guided Verteporfin Photodynamic Therapy for the Treatment of Unresectable Solid Pancreatic Tumors or Advanced Pancreatic Cancer, VERTPAC-02 Study

ClinicalTrials.gov study NCT03033225. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Study to Evaluate the Safety of BF-200 ALA (Ameluz®) for Photodynamic Therapy (PDT) in the Treatment of Expanded Fields of Actinic Keratosis (AK)

ClinicalTrials.gov study NCT04319159. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Interstitial Photodynamic Therapy (PDT) With Temoporfin for Advanced Head and Neck Cancers

ClinicalTrials.gov study NCT01415986. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)

ClinicalTrials.gov study NCT01846273. IPD Sharing: NO. Countries: 7. Publications: 4.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Photodynamic Therapy (PDT) With Levulan and Blue Light for the Treatment of Actinic Cheilitis

ClinicalTrials.gov study NCT02409732. IPD Sharing: Not stated. Countries: 1. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Daylight-mediated Photodynamic Therapy of Actinic Keratoses:Comparing 0.2%HAL With 16%MAL

ClinicalTrials.gov study NCT02149342. IPD Sharing: YES. Countries: 1. Publications: 1.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Efficacy Study for the Treatment of Non-Aggressive Basal Cell Carcinoma With Photodynamic Therapy

ClinicalTrials.gov study NCT02144077. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Efficacy/Safety of Verteporfin Photodynamic Therapy and Ranibizumab Compared With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization

ClinicalTrials.gov study NCT00436553. IPD Sharing: Not stated. Countries: 2. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Verteporfin Photodynamic Therapy Administered in Conjunction With Ranibizumab in Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration (AMD)

ClinicalTrials.gov study NCT00433017. IPD Sharing: Not stated. Countries: 12. Publications: 2.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Efficacy Study of Photodynamic Therapy With Levulan Kerastick + Blue Light for Actinic Keratoses on the Upper Extremities

ClinicalTrials.gov study NCT02137785. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Safety and Efficacy Study for the Field-directed Treatment of Actinic Keratosis (AK) With Photodynamic Therapy (PDT)

ClinicalTrials.gov study NCT01966120. IPD Sharing: NO. Countries: 1. Publications: 1.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov36/100

Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT).

ClinicalTrials.gov study NCT03573401. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov36/100

Controlled Study of the Occurrence of Actinic Keratosis on the Face After Cryotherapy + Aminolevulinic Acid (ALA) Photodynamic Therapy

ClinicalTrials.gov study NCT02239679. IPD Sharing: Not stated. Countries: 1. Publications: 1.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record